You are here


Aceleradora enfermedades raras AMMIC RIS3CAT Biocat

Acceleradora en Malalties Minoritàries de Catalunya (AMMIC) is part of the RIS3CAT community coordinated by Biocat. It is led by IUCT and other members include VHIR, Esteve, Aromics, BCN Peptides, Minoryx, Aniling and Qgenomics

BioRegio Catalunya febrer 2018

Firm led by Jordi Carrera hits archetypal milestone for sector amidst effervescent month of February

Catalan Healthtech MWC

The BioRegion of Catalonia has 110 healthtech companies and a new one is created every 20 days

The Start.Smart.Japan program includes a week of training in Munich on the barriers to the Japanese market and a mission to BioJapan


Publications in top journals, rounds of investment, licensing, benchmark events held in Barcelona... 2017 was a year full of good news for the BioRegion of Catalonia. Saying goodbye to the EMA and the political instability were the bittersweet counterpoint. What can we learn from these successes and failures? From research, enterprise and management, some of the main figures take stock. 

BIO Europe Spring 2017

Cutting-edge studies in the best international scientific publications, rounds of investment, licenses… despite saying goodbye to the EMA and the political instability of this last quarter of the year, the Catalan healthcare and life sciences sector has maintained its role as a global benchmark for this type of ecosystem.



The call for elections to choose the board of directors will open on 9 January




The Toyama Pharmaceutical Association visited the BioRegion on an ICEX reverse mission with collaboration from Biocat 


Barcelona will not host the European Medicines Agency, but the BioRegion of Catalonia is still one of the leading regions in healthcare & life sciences

Presentació estudi CataloniaBio i EY

Most of the funding comes from inside Catalonia, through venture capital funds, licensing deals and business angels and family offices, according to study from CataloniaBio and EY